Previous studies have shown that enhanced expression of mesenchymal markers, like N-cad and VIM, are important proteins in initiating EMT in tumours like the bladder, breast, colon, and prostate [64,65,66,67]. The gene discussed is CDH2; the disease is neoplasm.